{
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "synthetic",
    "ucits": true,
    "type": "ETP",
    "complex_factors": "Leverage, Futures-based replication, Compounding effect, High risk profile, Complex payoff structure",
    "classification": "complex",
    "supporting_data": "The product is a UCITS-eligible, fully collateralised Exchange Traded Product (ETP) providing 3x daily leveraged exposure to Gilts futures contracts. It uses futures (derivatives) as the primary replication method, not physical securities. The leverage is reset daily, introducing a compounding effect that can significantly deviate returns from a simple 3x multiple of the index over periods longer than one day, especially in volatile markets. The product is intended for informed retail investors who can bear loss of capital and have specific knowledge or experience in similar products. The risk indicator is 7 out of 7 (highest risk), reflecting the potential for very high losses. The structure, daily reset mechanism, and use of derivatives make the risks and payoff profile difficult for a retail investor with basic knowledge to understand. The productu2019s complexity is further highlighted by the explicit warning in the KID: 'You are about to purchase a product that is not simple and may be difficult to understand.' Under MiFID II, while UCITS are generally non-complex, structured UCITS or those employing complex strategies (such as significant derivative use or leverage) are considered complex and require an appropriateness assessment. This ETPu2019s reliance on futures for replication, daily leverage reset, and compounding effect place it firmly in the complex category, as it fails the MiFID II criteria for non-complex instruments (Article 57 of Delegated Regulation (EU) 2017/565), particularly due to the use of derivatives integral to the investment objective and the complexity of the risk-return profile."
}